{"preliminary_commentary":{"by_channel":{"x_thread":8,"youtube":4,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and posts on X and Bluesky that name this trial so far. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02642471\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":{"generated_at":"2026-11-22T14:52:06.336Z","note":"Automated from all 13 indexed sources (Oct 2021 – Oct 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice.","passages_read":13,"text":"- Whether sentinel node biopsy alone matches added pelvic lymphadenectomy for disease-free and cancer-specific survival\n- Whether omitting lymphadenectomy reduces lymphedema, lymphocyst and other surgical morbidity\n- Whether sentinel node biopsy alone should replace pelvic lymphadenectomy in early-stage cervical cancer practice\n- Whether the comparison holds in both the SLN-negative and SLN-positive cohorts","kind":"questions"},"drugs_tested":[],"indication":"early-stage cervical cancer","name":"PHENIX","nct_id":"NCT02642471","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=phenix-nct02642471. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"patients with negative sentinel nodes confirmed by pathological examination of frozen section will be randomly assigned to Arm 1 or Arm 2 Arm 1: patients undergo radical hysterectomy±salpingo-oophorectomy (no systematic pelvic lymphadenectomy) Arm 2: patients undergo radical hysterectomy±salpingo-oophorectomy+pelvic lymph node dissection","label":"Arm 1","type":"EXPERIMENTAL"},{"description":"patients with negative sentinel nodes confirmed by pathological examination of frozen section will be randomly assigned to Arm 1 or Arm 2 Arm 1: patients undergo radical hysterectomy±salpingo-oophorectomy (no systematic pelvic lymphadenectomy) Arm 2: patients undergo radical hysterectomy±salpingo-oophorectomy+pelvic lymph node dissection","label":"Arm 2","type":"NO_INTERVENTION"},{"description":"patients with positive sentinel nodes confirmed by pathological examination of frozen section will be randomly assigned to Arm 3 or Arm 4 Arm 3: patients undergo radical hysterectomy±salpingo-oophorectomy (no systematic pelvic lymphadenectomy) Arm 4: patients undergo radical hysterectomy±salpingo-oophorectomy+pelvic lymph node dissection","label":"Arm 3","type":"EXPERIMENTAL"},{"description":"patients with positive sentinel nodes confirmed by pathological examination of frozen section will be randomly assigned to Arm 3 or Arm 4 Arm 3: patients undergo radical hysterectomy±salpingo-oophorectomy (no systematic pelvic lymphadenectomy) Arm 4: patients undergo radical hysterectomy±salpingo-oophorectomy+pelvic lymph node dissection","label":"Arm 4","type":"NO_INTERVENTION"}],"collaborators":[],"completion_date":{"date":"2024-12-31","type":"ESTIMATED"},"conditions":["Cervical Cancer","Surgery","Quality of Life"],"enrollment":{"count":1080,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"no systematic pelvic lymphadenectomy","otherNames":[],"type":"PROCEDURE"}],"last_update":"2024-12-16","lead_sponsor":"Sun Yat-sen University","official_title":"Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)","overall_status":"ACTIVE_NOT_RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2024-12-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Disease free survival in PHENIX-I","timeFrame":"3 years"},{"measure":"Disease free survival in PHENIX-II","timeFrame":"2 years"}],"references":[{"citation":"Tu H, Huang H, Li Y, Chen X, Wang C, Zheng M, Zhang Y, Zhao W, Feng Y, Wan T, Huang Y, Yu A, Lu W, Xiao J, Shan W, Zhang P, Zhu C, Wang D, Zhou H, Li J, Kong B, Feng W, Wang X, Luo R, Huang X, Li J, Lin Z, Yao S, Liu J; PHENIX Investigators. Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer. N Engl J Med. 2025 Oct 16;393(15):1463-1474. doi: 10.1056/NEJMoa2506267.","pmid":"41092328","type":"DERIVED"},{"citation":"Tu H, Huang H, Xian B, Li J, Wang P, Zhao W, Chen X, Xie X, Wang C, Kong B, Xiao J, Zhang P, Liu J; PHENIX Investigators and the CSEM group. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010). Int J Gynecol Cancer. 2020 Nov;30(11):1829-1833. doi: 10.1136/ijgc-2020-001857. Epub 2020 Sep 24.","pmid":"32973117","type":"DERIVED"}],"start_date":{"date":"2015-12-31","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)","url":"https://clinicaltrials.gov/study/NCT02642471"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.3","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/phenix-nct02642471"}